Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer.
Publication Title
Endocrinology and metabolism clinics of North America
Document Type
Article
Publication Date
6-1-2022
Keywords
california; santa monica; sjci; Carcinoma, Neuroendocrine; Humans; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Thyroidectomy
Abstract
Medullary thyroid cancer is a rare thyroid malignancy with unique management considerations. In general, small intrathyroidal tumors are cured by total thyroidectomy with central compartment dissection, while large tumors and those with disease spread to regional lymph nodes and distant organs (most commonly lung, liver, and bone) are more difficult to cure. The last decade has seen significant progress in the treatment of advanced MTC, largely due to the discovery and availability of novel targeted therapies, including new drugs specifically targeting the RET protooncogone.
Area of Special Interest
Cancer
Area of Special Interest
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Oncology
